Mazars logo Mazars logo Mazars logo The Ledger

Mergers & Acquisitions PMO Assessment: Multinational Biopharmaceuticals Provider

Mergers & Acquisitions PMO Assessment: Multinational Biopharmaceuticals Provider



September 8, 2020

CHALLENGE

Client was experiencing integration challenges and wanted to evaluate their M&A PMO processes.

Existing challenges included:

  • Limited engagement from IT and other functional teams on merger and acquisition projects
  • No formal M&A plans place to own the requirements gathering, design, development, and implementation of network and telecommunications, virtual and physical infrastructure, core infrastructure services, security and support services, or messaging and collaboration
  • Very aggressive timeline with limited engagement and communication beyond corporate development team

HOW MAZARS HELPED

We assembled a team of skilled M&A and business process improvement professionals experienced in assessing PMOs.

Solution:

  • Provided robust assessment based on Merger Integration and Project Management Institute (PMI) best practices
  • Interviewed internal and external stakeholders and vendors to identify process gaps and opportunities to increase integration engagement and efficiency
  • Shared leverageable tools, templates and processes to develop a strategic approach to merger integration activity

THE RESULT

  • Successfully delivered M&A assessment and framework based on people, process, and technology success factors
  • Implemented an IT PMO strategic engagement model that:
    • Increased engagement, efficiency and communications in current and future integrations
    • Delivered improved success and value to future acquisition integrations

CONTACT

CHRIS MOORE | PARTNER, MANAGEMENT & TECHNOLOGY CONSULTING

(P)443.838.3050 | (E) chris.moore@mazarsusa.com

 

STEVEN KOPS | PARTNER, FINANCIAL ADVISORY SERVICES

(P)212.375.6852 | (E)steven.kops@mazarsusa.com

 

KEVIN KOCIS | DIRECTOR, MANAGEMENT & TECHNOLOGY CONSULTING

(P)623.628.2112  | (E)kevin.kocis@mazarsusa.com



Related posts




CHALLENGE Client had recently acquired three companies and needed an integration leader and a playbook to guide current


CHALLENGE Client needed M&A strategy, integration leadership, and a plan to drive technical enablement of the new acquisition.


CHALLENGE A heavily regulated biopharmaceutical client required an integration of disparate global governance systems. Existing challenges included: Need